Main Menu

Dr Susana Banerjee

Team Leader

The alt text
Dr Susana Banerjee’s (Reader in Women’s Cancers) research focuses on improving outcomes of women with gynaecological cancer through translational, research-driven clinical trials of novel therapies. She is a Consultant Medical Oncologist and Research Lead for The Royal Marsden NHS Foundation Trust Gynaecology Unit. Team: Gynaecological Cancers (Systemic Therapy and Clinical Trials)
+44 20 3437 6072

Biography

Dr Susana Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust. She is a Reader in Women’s Cancers and Team Leader in Gynaecological Cancers (Systemic Therapy and Clinical Trials) at the ICR. Dr Banerjee specialises in ovarian cancer and advanced endometrial and cervical cancers. She is a Theme Lead (Cancer Treatment Effects 2022-2027) for the National Institute for Health Research (NIHR) ICR/RM Biomedical Research Centre (BRC)

Dr Banerjee graduated with a 1st class degree from St John's College, University of Cambridge and completed her medical training at Royal Free Medical School, where she was a University of London Gold Medal Finalist.

Dr Banerjee was awarded an Avon Breast Cancer Crusade Clinical Fellowship for laboratory research and gained a PhD in 2009 from The Institute of Cancer Research, London. In 2007, she was awarded the San Antonio Breast Cancer Symposium Novartis Oncology Basic Science Award for her research.

Other prizes include the Association of Cancer Physicians McElwain Prize, Sir Antony Driver Prize (ICR) and Pfizer British Oncology Association Young Investigator Award (highly commended). She completed specialist medical oncology training at The Royal Marsden and was appointed a Consultant in 2011. In June 2015, she re-joined the ICR and gained the title of Reader in Women’s Cancers at the ICR in 2019.

Dr Banerjee has been part of national and international specialist groups, including the National Cancer Research Institute Gynaecological Cancers Clinical Studies Group, European Organization for Research and Treatment of Cancer (EORTC) Executive Steering Committee for Gynaecological Cancers, the European Society of Medical Oncology (ESMO) Gynaecological Cancers Faculty. She was scientific co-chair of the ESMO Asia Congress in 2018 and co-chair of the ESMO Gynaecological Cancers Annual Congress (2021-2024). She was part of the ESMO Women for Oncology Committee, and is Chair of the ESMO Resilience Task Force. Dr Banerjee served on the ESMO Executive Board and was elected ESMO Director of Membership (2020-2022). She is a member of the Medical Advisory Board for the Ovacome UK charity.

She is actively involved in clinical trials and translational research. Her research interests include individualisation of patient treatment and targeted therapies in gynaecological cancers including rare malignancies. Dr Banerjee is co-chair of the Gynecological Cancer InterGroup (GCIG) Rare Cancers Committee. Dr Banerjee is UK and Global Chief Investigator for a number of national and international clinical trials. 

Dr Banerjee has active collaborations with other ICR teams – Professor Chris Lord (Gene Function Team), Dr Rachael Natrajan (Functional Genomics), Professor Jessica Downs (Epigenetics and Genome Stability) and Professor Udai Banerji (Clinical Pharmacology and Trials). She supervises MD(Res) and PhD clinical fellows.